Clinical Trial: Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS
Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational
Official Title: Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS
Brief Summary: To observe the effect of goserelin 3,6mg sc depot injection by assessment of the mean percent reduction scores for symptoms: dysmenorrhoea, dyspareunia and pelvic pain; to observe the effect of goserelin 3,6mg sc depot injection by assessment of the mean percent reduction scores for pelvic tenderness and indurations; to observe the reduction in the proportion of patients requiring analgesics for the relief of pelvic pain for 6 months in patients treated with Zoladex 3.6 mg.
Detailed Summary:
Sponsor: AstraZeneca
Current Primary Outcome: Biberoglu and Bergham Scale [ Time Frame: monthly/ at every clinic visit- 6 times for symptoms: dysmenorrhoea, dyspareunia and pelvic pain ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Biberoglu and Bergham Scale [ Time Frame: twice/first and last clinic visit for pelvic tenderness and indurations ]
Original Secondary Outcome: Same as current
Information By: AstraZeneca
Dates:
Date Received: September 26, 2008
Date Started: October 2008
Date Completion:
Last Updated: September 8, 2009
Last Verified: September 2009